CORRESP: Correspondence
Published on April 16, 2025
VOLITIONRX LIMITED
1489 West Warm Springs Road, Suite 110
Henderson, Nevada 89014
April 16, 2025
SUBMITTED VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Lauren Hamill
| Re: | VolitionRx Limited’s Acceleration Request |
|
| Registration Statement on Form S-3 |
|
| Filed November 8, 2024 |
|
| File No. 333-283088 |
Requested Date: April 18, 2025
Requested Time: 5:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective as of the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.
Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth LLP, via telephone at (949) 725-4136 or via email at malcser@stradlinglaw.com or, in his absence, Amanda McFall, via telephone at (949) 725-4029 or via email at amcfall@stradlinglaw.com. We respectfully request that you contact Mr. Alcser or Ms. McFall via telephone as soon as the above referenced Registration Statement has been declared effective.
Sincerely, | ||
|
|
|
| VOLITIONRX LIMITED |
|
/s/ Cameron Reynolds | ||
Cameron Reynolds | ||
President and Chief Executive Officer |
cc:
VolitionRx Limited
Terig Hughes, Chief Financial Officer
Stradling Yocca Carlson & Rauth LLP
Marc G. Alcser, Esq.
Amanda McFall, Esq.